Safety Results IIIb: Significant Adverse Events by AE Risk Report in JMP® Clinical
In our recent paper, CDISC Enables Efficient Streamlining of Clinical Trial Safety Evaluation 1 ,2 , we followed FDA NDA (New Drug Application) or CR (Clinical Reviews) templates to show how drug sa...